Loading term…
In the US, the prescribing information (PI) that accompanies the drug and is intended for healthcare professionals. Contains full prescribing and safety information.
The US package insert includes indications, dosage, contraindications, warnings, and adverse reactions as approved in the NDA/BLA.
21 CFR 201.100, 201.57
Distributing promotional material that contradicts or minimises information in the package insert.
How do you ensure all promotional and medical materials are consistent with the approved labeling?